Skip to main content

Connaughton Bernadette

In the past year, 8 open-market sale filings worth $989.9K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$989.9K
8 filings
Net
−$989.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Connaughton Bernadette as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HALO Halozyme Therapeutics, Inc.

Director9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 2, 2025 (view filing)Sep 2Same dayConnaughton BernadetteDirectorSSale−4.00K$73.69−$294.7K−7.9%47.0K after3 lots10b5-1
Oct 1, 2025 (view filing)Oct 1Same dayConnaughton BernadetteDirectorSSale−2.00K$75.24−$150.5K−4.3%45.0K after2 lots10b5-1
Nov 12, 2025 (view filing)Nov 102 daysConnaughton BernadetteDirectorSSale−2.00K$68.48−$137.0K−4.4%43.0K after10b5-1
Dec 1, 2025 (view filing)Dec 1Same dayConnaughton BernadetteDirectorSSale−829$71.60−$59.4K−1.9%42.1K after10b5-1
Jan 6, 2026 (view filing)Jan 51 dayConnaughton BernadetteDirectorSSale−2.00K$70.25−$140.5K−4.7%40.1K after10b5-1
May 5, 2026 (view filing)May 14 daysConnaughton BernadetteDirectorSSale−1.63K$63.48−$103.2K−4.1%38.5K after10b5-1
Jun 2, 2026 (view filing)Jun 11 dayConnaughton BernadetteDirectorSSale−1.63K$66.21−$107.6K−3.6%43.7K after10b5-1
Jul 2, 2026 (view filing)4:42 PM ETJul 11 dayConnaughton BernadetteDirectorSSale−1.63K$76.71−$124.7K−3.7%42.0K after2 lots10b5-1
Aug 11, 2026 (view filing)5:43 PM ETAug 101 dayConnaughton BernadetteDirectorSSale−1.63K$102.80−$167.2K−3.9%40.4K after10b5-1